133 related articles for article (PubMed ID: 32576284)
1. Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study.
Gajewska KA; Bennett K; Biesma R; Sreenan S
BMC Endocr Disord; 2020 Jun; 20(1):92. PubMed ID: 32576284
[TBL] [Abstract][Full Text] [Related]
2. Availability of and access to continuous subcutaneous insulin infusion therapy for adults with type 1 diabetes in Ireland.
Gajewska KA; Biesma R; Bennett K; Sreenan S
Acta Diabetol; 2020 Jul; 57(7):875-882. PubMed ID: 32124077
[TBL] [Abstract][Full Text] [Related]
3. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
4. Barriers and facilitators to accessing insulin pump therapy by adults with type 1 diabetes mellitus: a qualitative study.
Gajewska KA; Biesma R; Bennett K; Sreenan S
Acta Diabetol; 2021 Jan; 58(1):93-105. PubMed ID: 32862261
[TBL] [Abstract][Full Text] [Related]
5. Use and Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Insulin Injection Therapy (MIT) in Children, Adolescents and Young Adults with Type 1 Diabetes Mellitus.
Schiel R; Burgard D; Perenthaler T; Stein G; Kramer G; Steveling A
Exp Clin Endocrinol Diabetes; 2016 Feb; 124(2):99-104. PubMed ID: 26895277
[TBL] [Abstract][Full Text] [Related]
6. Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injection therapy: data from the German/Austrian DPV registry.
Grammes J; Küstner E; Dapp A; Hummel M; Kämmer JC; Kubiak T; Schütz-Fuhrmann I; Zimny S; Bollow E; Holl RW;
Diabet Med; 2020 May; 37(5):856-862. PubMed ID: 31853984
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and incidence of type 1 diabetes in Ireland: a retrospective cross-sectional study using a national pharmacy claims data from 2016.
Gajewska KA; Biesma R; Sreenan S; Bennett K
BMJ Open; 2020 Apr; 10(4):e032916. PubMed ID: 32312725
[TBL] [Abstract][Full Text] [Related]
8. Continuous Subcutaneous Insulin Infusion Initiation Is Associated With Blood Pressure Reduction in Adults With Type 1 Diabetes.
Markakis K; Alam T; Jinadev P; Chapman A; Urwin A; Thabit H; Boulton AJM; Rutter MK; Leelarathna L
J Diabetes Sci Technol; 2019 Jul; 13(4):691-697. PubMed ID: 30636544
[TBL] [Abstract][Full Text] [Related]
9. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
Olsen B; Johannesen J; Fredheim S; Svensson J;
Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Effectiveness of Continuous Subcutaneous Insulin Infusion in the Prevention of Hypoglycemia in Adults with Type 1 Diabetes.
Summers JC; Briganti EM; Fitzgerald ZA; Lambers LNJ; Cohen ND
Diabetes Technol Ther; 2019 Aug; 21(8):423-429. PubMed ID: 31180239
[No Abstract] [Full Text] [Related]
11. Type 1 Diabetes and Long-Term Continuous Subcutaneous Insulin Infusion Therapy: A 10-Year Experience from Macedonia.
Petrovski G; Zivkovic M; Stratrova SS; Todorova BJ
Diabetes Technol Ther; 2017 Dec; 19(12):739-743. PubMed ID: 28976785
[TBL] [Abstract][Full Text] [Related]
12. [Continuous subcutaneous insulin infusion in children less than 6 years-old: long-term progress].
Colino E; Martín Frías M; Roldán B; Álvarez MÁ; Yelmo R; Barrio R
An Pediatr (Barc); 2017 Nov; 87(5):276-283. PubMed ID: 28233713
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in Danish children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections.
Birkebaek NH; Kristensen LJ; Mose AH; Thastum M;
Diabetes Res Clin Pract; 2014 Dec; 106(3):474-80. PubMed ID: 25451903
[TBL] [Abstract][Full Text] [Related]
14. Young people with type 1 diabetes mellitus: Attitudes, perceptions, and experiences of diabetes management and continuous subcutaneous insulin infusion therapy.
Perry L; James S; Steinbeck K; Dunbabin J; Lowe J
J Eval Clin Pract; 2017 Jun; 23(3):554-561. PubMed ID: 28052468
[TBL] [Abstract][Full Text] [Related]
15. Sociodemographic and psychosocial factors associated with continuous subcutaneous insulin infusion in adolescents with type 1 diabetes.
Cortina S; Repaske DR; Hood KK
Pediatr Diabetes; 2010 Aug; 11(5):337-44. PubMed ID: 19761529
[TBL] [Abstract][Full Text] [Related]
16. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
17. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.
Misso ML; Egberts KJ; Page M; O'Connor D; Shaw J
Cochrane Database Syst Rev; 2010 Jan; (1):CD005103. PubMed ID: 20091571
[TBL] [Abstract][Full Text] [Related]
18. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
[TBL] [Abstract][Full Text] [Related]
19. The use of continuous subcutaneous insulin infusion (CSII) as the treatment of choice in children and adolescents with type 1 diabetes.
Battelino T; Ursic-Bratina N; Bratanic N; Zerjav-Tansek M; Avbelj M; Krzisnik C
Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():537-9. PubMed ID: 16444189
[TBL] [Abstract][Full Text] [Related]
20. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
